Hal R. Werner
Founder at HealthCare Ventures LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dan R. Burns | M | 72 |
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | 17 years |
| Robert A. Vukovich | M | - |
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | 23 years |
| James Cavanaugh | M | 87 |
Middlebrook Pharmaceuticals, Inc.
 Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX.
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | 35 years |
| William W. Crouse | M | 80 |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts.
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | 12 years |
| Kim Graham | M | - |
Innomab, Inc.
 Innomab, Inc. Medical/Nursing ServicesHealth Services Innomab, Inc. provides medical services. It specializes in development of innovative monoclonal antibodies in oncology. The company was founded by Kristine Chavez, Kim Graham, and Chuck Smith in 2008 and is headquartered in Redwood City, CA. | 16 years |
| Kristine Chavez | F | - |
Innomab, Inc.
Innomab, Inc. Medical/Nursing ServicesHealth Services Innomab, Inc. provides medical services. It specializes in development of innovative monoclonal antibodies in oncology. The company was founded by Kristine Chavez, Kim Graham, and Chuck Smith in 2008 and is headquartered in Redwood City, CA. | 16 years |
| Chuck Smith | M | - |
Innomab, Inc.
Innomab, Inc. Medical/Nursing ServicesHealth Services Innomab, Inc. provides medical services. It specializes in development of innovative monoclonal antibodies in oncology. The company was founded by Kristine Chavez, Kim Graham, and Chuck Smith in 2008 and is headquartered in Redwood City, CA. | 16 years |
| Michael Porter | M | 76 |
Harvard Business School
| 51 years |
| Augustine Lawlor | M | 67 |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | 24 years |
| Chris Mirabelli | M | 69 |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | 24 years |
| John W. Littlechild | M | 72 |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | 32 years |
| Patrick Enright | M | 62 |
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | 18 years |
| Doug Onsi | M | 55 |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | 17 years |
| E. Ronald Goldfuss | M | - |
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | 19 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Douglas Swirsky | M | 54 | 11 years | |
| David P. Becker | M | 57 |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | 3 years |
| James Vincent Lambert | M | 60 | 11 years | |
| Eric Aguiar | M | 62 |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | 5 years |
| Beth A. Burnside | M | 63 |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | 7 years |
| Jeffrey Church | M | 67 | 8 years | |
| Timothy L. Miller | M | 67 |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | 3 years |
| Steven Shallcross | M | 62 |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | 4 years |
| Edward Rudnic | M | 68 |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | 9 years |
| David P. Wright | M | 75 | 1 years | |
| Robert F. Baltera | M | 58 | 4 years | |
| Bruce Carter | M | 80 | 8 years | |
| Brad Cole | M | 56 |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | 3 years |
| Atul Saran | M | 50 | 3 years | |
| Marc R. Schneebaum | M | 69 | 10 years | |
| Mark Leschly | M | 55 |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | 5 years |
| Jonathan Fleming | M | 66 | 2 years | |
| William N. Kelley | M | 84 | 15 years | |
| Thomas H. Fraser | M | - | - | |
| Zola P. Horovitz | M | 89 | 11 years | |
| Richard Borenstein | M | - |
Harvard Business School
| 2 years |
| John Day | M | 76 |
Harvard Business School
| 2 years |
| Mike Weingarten | M | - |
Harvard Business School
| 2 years |
| Nadir Burjorji Godrej | M | 72 |
Harvard Business School
| 2 years |
| Javid Hamid | M | - |
Harvard Business School
| 2 years |
| Mario Modiano | M | - |
Harvard Business School
| 2 years |
| Celia H. Currin | F | 76 |
Harvard Business School
| 2 years |
| Bob Louis Cummings | M | 86 |
Harvard Business School
| 2 years |
| Richard Thornburgh | M | 71 |
Harvard Business School
| 2 years |
| Delfin C. Gonzalez | M | 74 |
Harvard Business School
| 2 years |
| Guido de Vivo | M | 79 |
Harvard Business School
| 2 years |
| Michael Weingarten | - | - |
Harvard Business School
| 2 years |
| Thierry Bungener | M | - |
Harvard Business School
| 2 years |
| Bernard H. Lirola | M | - |
Harvard Business School
| 2 years |
| Michael C. Appel | M | 73 |
Harvard Business School
| 2 years |
| Michael Dubin | M | - |
Harvard Business School
| 4 years |
| John F. Seegal | M | - |
Harvard Business School
| 2 years |
| Bill Jesse | M | - |
Harvard Business School
| 2 years |
| Ken Freeman | M | - |
Harvard Business School
| 2 years |
| Edward Albert Nassim | M | 78 |
Harvard Business School
| 2 years |
| Luiz Francisco Novelli Viana | M | 74 |
Harvard Business School
| 2 years |
| Kwok Lun Fung | M | 75 |
Harvard Business School
| 2 years |
| Bob Newell | - | - |
Harvard Business School
| 2 years |
| Nik Amartefio | M | 79 |
Harvard Business School
| 2 years |
| Brian Hahn | M | 49 |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | 7 years |
| Joyce Fensterstock | F | - |
Harvard Business School
| 2 years |
| Richard A. Urquhart | M | 77 |
Harvard Business School
| 2 years |
| Mark Elliot Kingdon | M | - |
Harvard Business School
| 2 years |
| Raymond Bachand | M | 76 |
Harvard Business School
| 2 years |
| Del Marting | M | 77 |
Harvard Business School
| 2 years |
| Bruce Failing | M | - |
Harvard Business School
| 2 years |
| John R. Preston | M | - |
Harvard Business School
| 2 years |
| George Siguler | M | 77 |
Harvard Business School
| 2 years |
| Michael Quinn Anthony | M | 76 |
Harvard Business School
| 2 years |
| James Lawrence | M | 70 |
Harvard Business School
| 2 years |
| Michael Carpenter | M | 75 |
Harvard Business School
| 2 years |
| Susan S. Denison | F | 78 |
Harvard Business School
| 2 years |
| Eula Adams | M | 74 |
Harvard Business School
| 2 years |
| Mun Tak Yang | F | 70 |
Harvard Business School
| 2 years |
| Stephen M. Bachelder | M | 73 |
Harvard Business School
| 4 years |
| Joel Peterson | M | 77 |
Harvard Business School
| 2 years |
| Richard P. Schneider | M | 76 |
Harvard Business School
| 2 years |
| Franklin Berger | M | 74 |
Harvard Business School
| 2 years |
| Boon Hwee Koh | M | 73 |
Harvard Business School
| 2 years |
| Thomas Edelman | M | 73 |
Harvard Business School
| 2 years |
| Peter van Oppen | M | 71 |
Harvard Business School
| 2 years |
| Leon Black | M | 73 |
Harvard Business School
| 2 years |
| Arnold E. Spangler | M | - |
Harvard Business School
| 2 years |
| Robert Newell | M | 76 |
Harvard Business School
| 2 years |
| Denis Hanley | M | 76 |
Harvard Business School
| 2 years |
| Mark Throdahl | M | 73 |
Harvard Business School
| 2 years |
| Ralph Z. Sorenson | M | 90 |
Harvard Business School
| 10 years |
| Ed Kane | M | - |
Harvard Business School
| 2 years |
| Samer Khanachet | M | 73 |
Harvard Business School
| 2 years |
| Yves Barbieux | M | 85 |
Harvard Business School
| 2 years |
| Paul Addison | M | 77 |
Harvard Business School
| 2 years |
| Leo J. Corbett | M | - |
Harvard Business School
| 2 years |
| Al Hubbard | M | 76 |
Harvard Business School
| 2 years |
| Susan E. Engel | F | 77 |
Harvard Business School
| 2 years |
| Arthur Charles Spinner | M | 73 |
Harvard Business School
| 2 years |
| Jean-René Halde | M | 75 |
Harvard Business School
| 2 years |
| Brinck Lowery | M | - |
Harvard Business School
| 2 years |
| Richard John Glasebrook | M | - |
Harvard Business School
| 2 years |
| James Nathan Bailey | M | 76 |
Harvard Business School
| 2 years |
| Jerrell Shelton | M | 76 |
Harvard Business School
| 2 years |
| Stephen Holmes | M | - |
Harvard Business School
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hal R. Werner
- Personal Network
